A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure (Q84132371)
Jump to navigation
Jump to search
scientific article published on 01 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure |
scientific article published on 01 May 2010 |
Statements
A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure (English)
Runlin Gao
Jian Zhang
Liuquan Cheng
Xuesi Wu
Wei Dong
Xinchun Yang
Tianchang Li
Xifu Liu
Yabei Xu
Xinyan Li
Mingdong Zhou